In contrast to the increases observed in the fusiform gyrus and lateral temporal cortex, the increase in [18F]THK-5117 binding in the hippocampus was modest even in patients with AD (Table 2), suggesting that the tau pathology in the hippocampus reaches a plateau in an earlier stage of AD compared to the pathology in the neocortex. Here, MAPT is linked to Alzheimer disease.